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Twenty-five years ago many of the topical remedies for superficial mycoses were irritating, 
toxic, or allergenic. Total x-ray depilation of the scalp was the accepted mode of therapy for 
tinea capitis. The introduction of topical nystatin for candidiasis and tolnaftate for dermato-
phytosis were major advances, but tinea capitis, onychomycosis, and chronic tinea pedis still 
presented problems. 
Soon after its introduction in 1958, griseofulvin became the definitive form of therapy for all 
types of dermatophytosis and played a major role in abolishing large-scale epidemics of tinea 
capitis in some countries. Recently, haloprogin and the imidazole derivatives, miconazole 
and clotrimazole, which are topically active against dermatophytes and Candida albicans , 
have become available. 
Selective indicator media for isolating dermatophytes are useful diagnostic tools, but 
quicker methods of diagnosis which require little interpretation are still lacking. Epidemio-
logic studies in Vietnam again revealed the effects of climate and occlusion on the prevalence, 
incidence, and severity of superficial mycoses and led to renewed interest in host 
susceptibility, environment, and prevention of infections. 
This review is a personal evaluation of the 
significant contributions made over the last 25 
years to the field of mycology as it relates to skin. 
In several instances, no single investigator can be 
identified as the sole originator of a new develop-
ment; some were achieved by the melding of 
numerous data observed at different centers. I 
regret that space does not permit me to record all 
who contributed to the evolving theories. 
ADVANCES IN DIAGNOSIS 
From the turn of the century to 1950, diagnosis 
of the superficial mycoses still depended on the 
visualization of fungal elements in potassium hy-
droxide preparations and culture in Sabouraud's 
medium. Interpretation of the slide preparations 
requires a degree of skill and experience that only a 
very small segment of the medical community 
possess. Whereas Sabouraud's medium is satisfac-
tory for isolating fungi from clean body surfaces, it 
often becomes contaminanted by saprophytic 
fungi and bacteria when scalp and toewebs are 
cultured. In 1953, Dr. Lucille Georg greatly en-
hanced techniques for culture when she and her 
co-workers formulated a more selective medium 
containing penicillin, streptomycin, and cyclohexi-
mide [1]. This medium and later modifications 
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containing chloramphenicol were widely used for 
the next 20 years, but mycologic expertise was 
needed to identify dermatophytes from other fungi . 
From 1960 on, the microbiology team of the 
Department of Dermatology at the University of 
Miami has been involved in field activities, princi-
pally with military populations. Under these con-
ditions, contamination of cultures was a serious 
drawback and virtually precluded accurate epide-
miology. Gram-negative bacteria frequently over-
grew the cultures from the feet of men operating in 
wet terrain. Blank and Rebell [2] introduced a 
two-tube technique to help separate dermato-
phytes from saprophytes by including griseofulvin 
in one tube. Taplin [3] introduced gentamicin as 
an antibacterial inhibitor. Encouraged by Baxter's 
report on the use of Ink Blue [4] as an indicator of 
pH changes in cultures of dermatophytes, the 
Miami team launched a 4-year project to perfect a 
selective identification medium for dermato-
phytes. Dermatophyte Test Medium (DTM) [5] 
was clinically tested on over 6000 patients and was 
a major factor in enabling field teams to accutately 
determine the epidemiology of the mycotic infec-
tions in Vietnam in 1967 and 1968, even under the 
dirty conditions of the Mekong Delta [6] . When 
DTM is made with the ingredients originally 
specified by Taplin et al [5], dermatophytes can be 
correctly scored in 97% of the cultures on the basis 
of color change alone. The fact that the few black 
and green molds that occasionally turn the me-
dium red can easily be recognized as contaminants 
increases the accuracy of the method even further. 
A large-scale study among soldiers in Colombia in 
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1974 and the use of authentic DTM to establish the 
clinical efficacy of clotrimazole and miconazole 
fully confirmed the value of the medium, which is 
also used widely in veterinary medicine. 
Other diagnostic aids which have been devel-
oped in the last 25 years include the introduction 
by Kligman and his co-workers of the periodic 
acid-Schiff (PAS) stain for fungi in tissues [7] and 
a time-saving addition to the KOH procedure by 
Zaias and Taplin who added dimethylsulfoxide 
(DMSO) to speed up the process of clearing the 
keratinocytes [8]. 
ADVANCES IN THERAPY 
A brief summary of the situation in 1950 will 
show that significant progress has been made in 
the management of the superficial mycoses. At 
that time, these infections constituted a significant 
proportion of dermatologic practice. The galaxy of 
medicaments used to treat them was evidence of 
the recalcitrant nature of many cases and of the 
need for specific antifungal antibiotics. Among the 
agents for topical therapy were phenol, formalin, 
tar, potassium permanganate, mercury com-
pounds, copper sulfate, salicylic acid, copper gly-
collate, sulfur, undecylenic acid, salicylanilide, 
gentian violet, silver nitrate, and Castellani's 
paint. Sulzberger's comment in the Year Book of 
Dermatology for 1950 was appropriate: " ... treat-
ment of superficial fungous infections today still 
depends mainly on physical and/or chemical re-
moval of the infected dead tissue and prevention of 
invasion of newly formed or forming horny and 
macerated nonviable materials." 
The new generation of "broad spectrum" anti-
bacterial antibiotics was on the scene, and within 
the next 3 years, oral and anogenital candidiasis 
was recognized as a possible side effect of the 
tetracyclines. Hopes were not high in 1950 that 
specific antifungal antibiotics would soon be intro-
duced. Another editorial comment in the Yearbook 
of Dermatology of 1950 concluded; "It appears 
highly unlikely that the advent of an antifungal 
antiobiotic which could be used systemically would 
cause a revolutionary change in the incidence or 
management of superficial fungus infections. It is 
also unlikely that any antibiotic should prove to 
have greater antifungal capacities than the medi-
caments now available for topical use, including 
mercurials, iodine, phenolic compounds, recorcinol 
and quinolines." There was little to encourage a 
more optimistic view. The antibiotics so far discov-
ered were disconcertingly inactive against fungi 
and yeasts. However, in the Division of Laborato-
ries and Research at the New York State Depart-
ment of Health, Brown and Hazen were studying 
two novel antibiotics produced by an actinomycete 
isolated from a pasture of the Nourse dairy farm in 
Virginia. The organism Streptomyces noursei elab-
orated the antifungal metabolites actidione and 
fungicidin, later renamed nystatin in recognition 
of the laboratory in which it was isolated and 
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destined to become the first specific antifungal 
antibiotic for human use. 
Beginning in 1940, an epidemic of fluorescent 
tinea capitis swept across the United States from 
the East Coast and by 1945 had reached huge 
proportions; five years later, it still had not abated. 
A new and more insidious threat was becoming 
noticeable, that of the increasingly frequent non-
fluorescent Trichophyton tonsurans infections 
from Mexico, which were becoming well estab-
lished in Texas and other Southwestern states. No 
longer was it safe to rely on Wood's light examina-
tions alone. Diagnosis was not the most significant 
problem, however; therapy posed a more serious 
challenge. Total epilation by x-ray therapy was 
regarded as the only really effective method of 
treatment, except for highly inflammatory lesions, 
which undergo spontaneous resolution. Total x-ray 
epilation of the scalp had been in vogue since 
Sabouraud and Noire had introduced it in 1904 
and was in full swing in the 1950s although the 
effects of ionizing radiation after Hiroshima and 
Nagasaki were fresh in the minds of physicians and 
the lay public. Nevertheless, the method was 
accepted as safe, provided it was conducted by 
well-trained and experienced personnel with well-
calibrated instruments. Unfortunately, this was 
not always the case. 
Since x-ray epilation alone was not considered 
effective, the best clinics combined it with kerato-
lytic agents and painstaking manual epilation of 
all stubs [9]. At the American Dermatological 
Association meeting at Hot Springs, Virginia, in 
May, 1951, Dr. Bedford Shelmire described the 
case of a woman infected with T. tonsurans who 
received two x-ray epilations and many topical 
agents and was finally cured after a nurse spent 
one hour each day, five days a week, for four 
months, manually pulling out diseased stubs or 
digging them out with a scalpel. Children were 
forced to forego school attendance for many 
months at a time or were allowed to attend school 
wearing a stocking cap over their shaved heads 
which marked them as one of the "untouchables." 
Having been picked on by the dermatologists, they 
were then picked on by their peers. Cutaneous 
scarring was a rarity, but the extent of the emo-
tional scarring endured by these children will never 
be fully known. 
This, then, was the situation 25 years ago. There 
was plenty of work for dermatologists, but few 
really dramatic advances since the early 1900s. 
During the next few years, reports were pu blished 
which more closely defined the problems, refined 
established techniques, and reiterated the lessons 
learned during World War II, particularly about 
personal foot care, fresh air, and powder as valua-
ble aids to the prevention of tinea pedis. Further 
toxic products such as topical asterol dihydrochlo-
ride and systemic thallium acetate were added to 
the therapy of tinea capitis. Meanwhile, the scien-
tific community and industry collaborated in the 
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development of nystatin, which still stands up to 
close scrutiny today. We owe much to Hazen and 
Brown, the scientists of the Squibb Institute of 
Research, and cooperating dermatologists who par-
ticipated in these early phases of developing the 
first true antifungal antibiotic [10]. 
By 1956, an effective treatment for candidiasis 
had been found . Unfortunately, the spectrum of 
clinical activity did not extend to dermatophyto-
sis. In 20 years of use , topical nystatin is still 
remarkably free of allergenic reactions; any reac-
tions reported with these preparations have been 
due to vehicle effects or preservatives incorporated 
in the products. Whether because of the knowledge 
gained during the developmental period or from 
some other source, sometime between 1954 and 
1956, prospects for a nontoxic systemic antifungal 
remedy brightened. Sulzberger and Baer [11], 
speaking of tinea capitis, wrote that" ... sub-
stantial improvement in the management of tinea 
capitis must await the discovery of some new 
means . . . for systemically administering some 
safe effective antifungal drug which will be prefer-
entially deposited in the invading hairs or the 
invaded parts of the skin, particularly its horny 
structure and appendages." And Wilson [12] 
wrote: "The ideal antifungal drug even for superfi-
cial mycoses would seem to be one which could 
safely be administered inter-tally in amounts suffi-
cient to endow the cells eventually destined to 
produce keratin with the power persisting as they 
become keratinized, and the drug thus exerting its 
effects from within outward." At the American 
Dermatological Association meeting in Santa Bar-
bara, California, June 8, 1956, Dr. Harvey Blank, 
speaking of the failure of dermatophytosis to 
respond to topical nystatin, opined that "Perhaps 
one of the newer antibiotics will prove more 
effective topically, but one cannot help but feel 
that ultimate success probably will come from 
another approach, possibly the systemic adminis-
tration of the antibiotic. " 
On August 16, 1958, an article appeared in 
Nature [13] which was to revolutionize the treat-
ment of dermatophytosis. In it , Dr. James C . 
Gentles described the preliminary results of ad-
ministering griseofulvin by mouth to guinea pigs 
infected with Micosporum canis and T . mentagro-
phytes. The number of animals used was not 
stated; only that those given the drug did not 
develop infections whereas control animals did . No 
untoward effects were observed. By today's stan-
dards, these meager data were totally inadequate 
to serve as a basis for human trials . Dr. Gentles 
was aware of this and of the inadequacy of current 
topical agents: "The purpose of this communica-
tion is to make available experimental results 
which may be of some importance for future 
progress in this hitherto unrewarding field of 
investigation. " 
The explosive progress which was to be made in 
the next six months must have astonished even Dr. 
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Gentles. In due course, Dr. Harvey Blank, chief of 
the still fledgling Division of Dermatology in the 
Department of Medicine at the University of 
Miami, read Dr. Gentles's report. At the time, he 
was treating a 27-year-old man with rheumatoid 
arthritis and a most vexing case of dermatophyto-
sis, manifest by ulcerating nodules and purulent 
abscesses over large areas of the body (14]. All at-
tempts at therapy had failed; the patient was al-
most completely lacking the normal antifungal fac-
tor which Roth et al (15] had described. He was 
started on 5 gm of oral griseofulvin per day, and his 
dramatic response drew immediate attention to 
the new drug. By the time the Academy of Derma-
tology met during the first week of December, 1958, 
Blank and co-workers had treated 31 cases and 
presented their findings . 
At the same time, Williams and his colleagues 
published the British experiences in a letter "to 
Lancet [16]. These findings made headlines 
around the world, and by the following year 
numerous publications had confirmed the success 
of griseofulvin. In Adelaide, Australia, for exam-
ple , x-ray epilation for tinea capitis was immedi-
ately abandoned as a result of the paper by 
Williams et a1. In a beautiful history and review of 
tinea capitis [17], Donald described how griseoful-
vin revolutionized the treatment of endothrix in-
fections among the aborigines of South Australia. 
Probably the most gratifying response to therapy 
occurred with tinea capitis. The ability to control 
epidemics among school children became a reality. 
Spurred by the availability of this new mode of 
therapy, the World Health Organization sponsored 
a program in Yugoslavia, in 1960, in which 94,296 
cases were found in 1,782,000 people screened [18]. 
The gravity of tinea capitis as a public health 
problem has greatly decreased as the direct result 
of the use of griseofulvin in countries that can 
afford it. 
The success of griseofulvin by no means deterred 
the search for new topical agents. Nystatin -was 
by now firmly established as an effective treatment 
for candidiasis. Scientists of the Nippon Soda 
Company in Japan were screening thousands of 
compounds for antifungal activity, and in 1962, 
Noguchi et al published the results of their work 
with a group of compounds they named naphthio-
mates [19]. These interesting compounds showed 
no activity against bacteria or yeasts but were 
highly effective against the dermatophyte fungi. 
Totally ineffective by the oral or parenteral route 
in guinea pigs, they were nonirritating and nons en-
sitizing when tested topically on infected animals. 
During 1963 and 1964, a 1 % solution of one of these 
either controlled or cured 73% of 520 patients in 19 
independent studies [20]. Over the next 10 years, 
tolnaftate solution was highly effective in the 
management of dermatophtosis of the skin, but 
like other topical agents, was of no use in tinea 
capitis or infections of the nails and was not 
curative in all cases of tinea corporis and tinea 
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pedis. It had, however, a very important advantage 
over previous remedies. Like nystatin, it was al-
most completely devoid of irritating or sensitizing 
properties. This fact, in my opinion, was respon-
sible for the much lower incidence of overtreat-
ment dermatitis in Vietnam than during World 
War II, when the harsh remedies then available 
often created more disability than the original in-
fections, especially in the Tropics. 
The success of nystatin and tolnaftate through-
out the Sixties, however, depended too much on 
the skill of the physician to diagnose the difference 
between candidiasis and dermatophytosis and to 
select the correct antibiotic. In most cases many 
dermatologists can make this distinction on clini-
cal grounds alone and many have developed this 
art to high levels of accuracy. All too often, 
however, the proper diagnosis is not made, or the 
patient has a mixed infection. In many instances, 
the condition is a priori judged to be another case 
of nonspecific intertrigo, which I have seen only 
rarely in surveys of many thousands of men and 
school children of both sexes. The average clinician 
without specialized training is ill equipped to make 
a specific diagnosis. 
A single mode of therapy would relieve this 
dilemma and would have dis"mct advantages. The 
introduction of the "broad spectrum" topical an-
tifungal agents which are equally effective against 
dermatophyte fungi and C. albicans has begun a 
new era in the treatment of skin infections. Halo-
pro gin from Japan, miconazole from Belgium, and 
clotrimazole from Germany have all evolved from 
the screening of synthetic agents for antifungal 
activity. All are now available in the United States 
and are being successfully used against candidiasis 
and dermatophytosis. It will be some time, how-
ever, before the relative efficacy and incidence of 
side effects of these new agents can be evaluated. 
Methods of scoring will have to be synchronized 
and more attention will have to be given to the 
type of vehicle in which topical antifl1ngals are 
incorporated. During the last half of the Seventies, 
however, highly potent broad-spectrum remedies 
are expected to be introduced which will be incor-
porated in cosmetically acceptable vehicles and 
will produce minimal side effects. 
ADVANCES IN EPIDEMIOLOGY 
Except for the excellent work performed in 
Vietnam by Allen et al [6], the epidemiology of 
dermatophytosis had improved very little during 
the past 25 years. I know of no evidence that the 
introduction of new forms of therapy has signifi-
cantly altered the incidence of infections. Whereas 
epidemics of tinea capitis in schools can be aborted 
by the use of griseofulvin, tinea pedis, for example, 
appears to be as prevalent as ever. Our own studies 
in the late Sixties among soldiers at Fort Benning 
showed that 75% of recruits suffered from labora-
tory-confirmed tinea pedis during the summer, the 
same prevalence found there by Hopkins in 1944 
[21]. Surveys of almost 200 university students in 
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Miami, who for the most part wore sandals or 
walked barefoot, showed a prevalence of only 14%. 
These unpublished data merely reconfirmed the 
significant study of Nickerson, Irving, and Meh-
mert at Eglin Field in 1944 [22], which showed that 
the wearing of open sandals instead of army shoes 
significantly reduced foot infections of all types. In 
this study involving over 2000 men, only 3.5% of 
the sandal group had serious foot problems after 
the 2-month study whereas 28% of the shoe group 
were in serious condition. In addition, the 900 men 
wearing shoes required 208 days of hospitalization 
for foot problems whereas the 1200 men wearing 
sandals required only 13 days. We still hold these 
truths to be self evident: the single most important 
factor that regulates the incidence, prevalence, 
and severity of tinea pedis is occlusion. 
During 1966 to 1969, large-scale epidemics of 
inflammatory dermatophytosis occurred among 
American troops in Vietnam. Blank, Taplin, and 
Zaias [23 J reported that these infections were due 
to zoophilic (granular) T. mentagrophytes, and 
Allen and Taplin [24] isolated the same fungus 
from rats trapped near the living quarters. No 
correlation was found between tinea pedis and the 
inflammatory lesions on other areas of the body 
which were not caused by exacerbation of preexist-
ing infections brought from the United States. 
Rippon [25] showed that unlike the usual Ameri-
can strains, the isolates from Vietnam were of the 
small (a) mating type. In my opinion, the epidem-
ics of T. mentagrophytes infection in Vietnam were 
the result of the crowding together of men, rats, 
and food supplies on small "islands" created as 
military bases in wet terrain. Similar epidemics of 
zoophilic T. mentagrophytes infections have been 
reported in man during plagues of field mice in 
South Australia [26 J. Curiously, the zoophilic T. 
mentagrophytes infections were not prevalent 
among adult Vietnamese nor even among their 
soldiers. The few cases seen in Vietnamese children 
suggested that adult immunity was acquired. A 
similar phenomenon was seen in streptococcal 
pyoderma, common among Vietnamese children 
and U. S. troops, but rare in adult natives. 
The Vietnamese adults were not immune to all 
dermatophytes, however. They had their own dis-
tinct variety of T. rubrum, which often caused 
chronic infections. So far, we have not seen this 
variety in the United States. Unlike the strains 
from the United States, the Vietnamese isolates 
regularly produced infections on the abdomens of 
volunteers of both sexes in studies conducted at the 
University of Miami. The field work in Vietnam 
was, I believe, an elegant reminder of the value of 
well-conducted epidemiologic field work. From it 
came a renewed interest in the immunologic as-
pects of host resistance, a much closer look at the 
effects of occlusion, new questions about the phar-
macology of griseofulvin and its use as a pro-
phylatic measure, and renewed interest in human 
models of dermatophytosis. 
In other areas of mycology, candidiasis is becom-
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ing an increasingly important problem. It is now 
seen as a life-threatening opportunistic pathogen 
in debilitated hospital patients, especially in those 
on cancer chemotherapy, immunosuppressive 
agents, and hyperalimentation. A safe systemic 
antibiotic for the treatment of candidiasis is yet to 
come. 
SUMMARY 
During the last 25 years significant advances 
have been made in the management of dermato-
phytosis and candidiasis. Harsh remedies, which 
caused irritation and "overtreatment" dermatitis, 
have largely been replaced by effective nonirritant, 
specific antifungal agents. New topical agents 
effective against dermatophytosis and superficial 
candidiasis are likely to replace other more specific 
topicals as prescription items. 
Epidemiologic studies in Vietnam and among 
other military populations have convincingly 
shown the important relation between climate, 
clothing, and occupation and the prevalence and 
severity of infections. Griseofulvin is still the 
treatment of choice for tinea capitis, onychomyco-
sis, and the more severe cases of dermatophytosis 
which do not respond to topical therapy. 
A safe systemic antibiotic for the emerging 
problem of life-threatening candidiasis in debili-
tated hospitalized patients is a major need. Micro-
scopic preparations and cultures for diagnosing 
superficial fungal infections are useful tools in the 
hands of only a small proportion of physicians and 
laboratory technologists. More precise, rapid 
means of diagnosis that do not require skilled 
interpretation are sorely needed. 
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